Effects of Alpha and Beta Receptor Stimulating and Blocking Agents on Experimental Disseminated Intravascular Coagulation

Summary

In this experimental study on rabbits, we compare the haemostatic and histological changes observed in animals with disseminated intravascular coagulation (DIC) induced by thrombin perfusion (100 u/kg/hr during 3 hours) with or without preventive administration of alpha and beta receptor stimulating or blocking agents.

Both alpha and beta receptor stimulating agents enhance the disorders induced by thrombin alone, while alpha or beta blocking agents reduce them.

This favourable action is still more pronounced with the combination of these two last types of drugs.

The modifications observed appear to be related to changes in platelet function.

^* Laboratory of Pathology.

• References

• 1 Berk J. L, Hagen J. F, Beyer W. H, Dochat G. R, Lapointe R. 1967; The treatment of haemorrhagic shock by beta adrenergic receptor blockade. Surgery, Gynecology and Obstetrics 125: 1.
• 2 Berk J. L, Hagen J. F, Beyer W. H, Gerberg M. J, Dochat G. R. 1969; The treatment of endotoxin shock by beta adrenergic blockade. Annals of Surgery 169: 74.
• 3 Born G. V. R, Cross M. J. 1963; The aggregation of blood platelets. Journal of Physiology 168: 178.
• 4 Born G. V. R, Mills D. C. B, Roberts G. C. K. 1967; Potentiation of platelet aggregation by adrenaline. Proceedings of the Physiological Society 191: 43.
• 5 Bucher H. W, Stucki P. 1969; The effect of various beta receptor blocking agents on platelet aggregation. Experientia 25: 280.
• 6 Bygdeman S, Johnsen O. 1969; Studies on the effect of adrenergic blocking drugs on catecholamine induced platelet aggregation and uptake of noradrenaline and 5 hydroxytryptamine. Acta physiologica Scandinavica 75: 129.
• 7 Caen J. 1961; Le temps de Stypven. Pathologie et Biologie 09: 180.
• 8 Cohen R. J, Epstein S. E, Cohen L. S, Dennis L. H. 1968; Alteration of fibrinolysis and blood coagulation induced by exercise and the role of beta adrenergic receptor stimulation. Lancet 02: 1264.
• 9 Halmagyi D. F. J, Starczecki B, Horner G. J. 1963; Mechanism and pharmacology of endotoxin shock in sheep. Journal of Applied Physiology 18: 544.
• 10 Hampton J. R, Harrisson H. J. G, Honour A. J, Mitchell J. R. A. 1967; Platelet behaviour and drugs used in cardiovascular diseases. Cardiovascular Research 02: 101.
• 11 Hellem A. J. 1970; Platelet adhesiveness in von Willebrand’s disease. Scandinavian Journal of Haematology 07: 374.
• 12 Ingram G. I. C. 1961; Increase in antihaemophilic globulin activity following infusion of adrenaline. Journal of Physiology 156: 217.
• 13 Janssen C. L, Masure R. 1970; Enzymatic method for the quantitative determination of factor XIII. Application to a familial deficiency. Pathologia europaea 05: 315.
• 14 Joist J. H, Pechan J, Gross R. 1970. The effect of beta receptor blocking agents on platelet function in vitro and in vivo. In: Platelets and the vessel wall fibrin deposition. Gotthard Schettler. Georg Thieme Verlag; Stuttgart: 59.
• 15 Kardos G. G. 1966; Isoproterenol in the treatment of shock due to bacteremia with gram negative pathogens. New England Journal of Medicine 274: 868.
• 16 Kubisz P, Levy Toledano S, Cronberg S, Pinkhas J, Caen J. 1970; Effect of phentolamine, an alpha receptor blocking agent on epinephrine, ADP and collagen induced platelet factor 4 release and platelet aggregation. Revue européenne d’études cliniques et biologiques 15: 429.
• 17 Kubisz P, Suranova J. 1972; The effect of alpha and beta receptor blocking agents on collagen induced platelet release reaction. Thrombosis et Diathesis Haemorrhagica 27: 278.
• 18 Kubisz P, Caen J. 1972; Interaction of alpha and beta receptor blocking agents with platelet release and availability reaction induced by ADP, adrenaline and collagen. Pathologie et Biologie 20: 34.
• 19 Lillehei R. C, Longerbeam J. K, Block J. H, Massax W. G. 1964; The modern treatment of shock based on physiologic principles. Clinical Pharmacology and Therapeutics 05: 63.
• 20 McClure P. D, Ingram G. I. C, Jones V. G. 1965; Platelet changes after adrenalin infusions with and without adrenaline blockers. Thrombosis et Diathesis Haemorrhagica 13: 136.
• 21 McKay D. G. 1969; Tissue damage in disseminated intravascular coagulation, mechanism of localization of thrombi in the microcirculation. Thrombosis et Diathesis Haemorrhagica suppl. 36: 67.
• 22 McKay D. G, Latour J. G, Parrish M. H. 1970; Activation of Hageman factor by alpha adrenergic stimulation. Thrombosis et Diathesis Haemorrhagica 23: 417.
• 23 McKay D. G, Latour J. G, Lopez A. M. 1971; Production of generalized Shwartzman reaction by activated Hageman factor and alpha adrenergic stimulation. Thrombosis et Diathesis Haemorrhagica 27: 71.
• 24 McLean L. D, Duff J. H, Scott H. M, Peretz D. I. 1965; Treatment of shock in man based on haemodynamic diagnosis. Surgery, Gynecology and Obstetrics 120: 1.
• 25 Mills D. C. B, Roberts G. C. K. 1967; Effect of adrenaline on human blood platelets. Journal of Physiology 193: 443.
• 26 Moriatt M. 1969; Inhibiteurs naturels de la fibrinolyse et phénomènes thrombohémorra- giques. Pathologia europaea, 4, suppl 01: 1.
• 27 Müller Berghaus G, Davidson E, McKay D. G. 1967; Prevention of the generalized Shwartzman reaction in pregnant rats by alpha adrenergic blockade. Effect on the coagulation mechanism. Obstetrics and Gynecology 30: 11.
• 28 Müller Berghaus G. 1969; Pathophysiology of disseminated intravascular coagulation. Thrombosis et Diathesis Haemorrhagica, suppl 36: 45.
• 29 Nickerson M. 1962. Drug therapy of shock. In: Shock, Pathogenesis and Therapy. K. Bock; Springer. Berlin: 356.
• 30 O’Brien 1963; Some effects of adrenaline and antiadrenaline compounds on platelets in vitro and in vivo. Nature 200: 763.
• 31 Palmiero C, Ming S. C, Frantz E, Fine J. 1962; The role of the sympathetic nervous system in the generalized Shwartzman reaction. Journal of Experimental Medicine 115: 609.
• 32 Ponari O, Cvardi E, Megha A, Pini M, Poti R, Dettori A. G. 1973; Effect of alpha and beta blocking drugs on the clotting and fibrinolytic respons to venous stasis in man. British Journal of Haematology 24: 463.
• 33 Rysanek K, Svehla C, Spankova M, Mlejnkova M. 1968; Comparison on the effect of various sympathicolytics on thrombocytes aggregation. Journal of Pharmacy and Pharmacology 20: 154.
• 34 Sacchetti G, Bellani D, Montanari C, Gibelli A. 1973; Effects in vitro of some cardiovascular drugs and other agents on human platelet aggregation. Thrombosis et Diathesis Haemorrhagica 29: 190.
• 35 Starzecki B, Reddin J. L, Spink W. W. 1968; Effect of isoproterenol on survival in canine endotoxin shock. Annals of Surgery 167: 35.
• 36 Thomas D. P. 1967; Effect of catecholamines on platelet aggregation caused by thrombin. Nature 215: 198.
• 37 Vick J. A, Cinchta H. P, Mantheri J. H. 1965; Use of isoproterenol and phenoxybenzamine in treatment of endotoxin shock. Journal of Pharmacology and Experimental therapeutics 150: 382.
• 38 Weiss H. J. 1972. The pharmacology of platelet inhibition. In: Spaet T. h.H. (ed.) Progress in Hemostasis and Thrombosis. vol. 1. Grune and Stratton; New York and London: 199.
• 39 Whitaker A. N, McKay D. G, Csavossy I. 1969; Studies of cathecolamine shock. American Journal of Pathology 56: 153.
• 40 Yamazaki M, Sano T, Odakura T, Takencki K, Metsumura T, Hosaki S, Shimamoto T. 1971; Appearance of thrombogenic tendency induced by adrenaline and its prevention by beta adrenergic blocking agents, nialamide and pyridinolcarbamate. Thrombosis et Diathesis Haemorrhagica 26: 251.
• 41 Yamazaki H, Kobayashi I, Sano T, Shimamoto T. 1973; Enhancement of ADP induced platelet aggregation by adrenaline in vivo and its prevention. Thrombosis et Diathesis Haemorrhagica 29: 490.